This attack does 30 damage to 1 of your opponent's Pokémon for each Darkness Energy attached to this Pokémon. (Don't apply Weakness and Resistance for Benched Pokémon.)
Brilliant Stars was released in 2022. It belongs to the Sword & Shield series.
With 186 listed cards, this is a large set by modern TCG standards. As of 2026, the set is 4 years old and sits in a modern-era collecting window.
In the Brilliant Stars checklist, Grimmsnarl occupies position #94 as a Rare card.
Grimmsnarl is a Brilliant Stars card from the 2022 release window. The printed flavor text states: "With the hair wrapped around its body helping to enhance its muscles, this Pokémon can overwhelm even Machamp." Its card type is Pokémon.
The rarity label is Rare. Printed HP is 160.
Energy typing is Darkness. This gives collectors a clear identity footprint for the print.
Grimmsnarl evolves from Morgrem. Attack line includes "Longhair Shot" and "Darkness Fang".
Grimmsnarl (Brilliant Stars) is presently valued at about $0.14 in raw condition. The 7-day delta remains near neutral at 0.0%.
Relative to the last 30 days, value is near baseline at $0.14. Its 90-day trading band runs between $0.12 and $0.18, producing a 43% range and moderate-volatility behavior.
The listed rarity for this print is Rare.
A wider Grimmsnarl checklist helps contextualize this specific Grimmsnarl print. Comparable entries in this snapshot: 5 cards, 5 distinct sets.
Observed alternatives run from $0.07 to $2.08 (2871% spread). The current card sits -75% versus the sampled alternative average of $0.56.
Notable alternatives include Grimmsnarl #178 (Fusion Strike) at $0.20, Grimmsnarl #SV085 (Shining Fates Shiny Vault) at $2.08, Grimmsnarl #125 (Rebel Clash) at $0.29, and Grimmsnarl #73 (Journey Together) at $0.07.
Collector-focused market read: The latest week is near flat (0.0%), suggesting consolidation rather than breakout behavior. Observed 90-day bounds of $0.12 and $0.18 create a 43% band, matching a moderate-volatility profile.
Current value remains close to its 30-day mean ($0.14). Top-grade copies show substantial separation from raw: PSA 10 is pricing +42757% above the current raw benchmark.
PSA 9 is currently around $11.00, while PSA 10 is $60.00.
